 Connection
Fiona Zwald to Middle Aged
This is a "connection" page, showing publications Fiona Zwald has written about Middle Aged.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.135 |
|
|
|
-
Zwald FO, Sargen MR, Austin AA, Hsieh MC, Pawlish K, Li J, Lynch CF, Yu KJ, Engels EA. Outcomes in solid organ transplant recipients with a pretransplant diagnosis of melanoma. Am J Transplant. 2024 Jun; 24(6):993-1002.
Score: 0.047
-
Zhang S, Mina MA, Brown MD, Zwald FO. Retention of Mohs surgeons in academic dermatology. Dermatol Surg. 2015 Aug; 41(8):903-12.
Score: 0.026
-
Zwald FO, Spratt M, Lemos BD, Veledar E, Lawrence C, Marshall Lyon G, Chen SC. Duration of voriconazole exposure: an independent risk factor for skin cancer after lung transplantation. Dermatol Surg. 2012 Aug; 38(8):1369-74.
Score: 0.021
-
McCoppin HH, Christiansen D, Stasko T, Washington C, Martinez JC, Brown MD, Zwald FO. Clinical spectrum of atypical fibroxanthoma and undifferentiated pleomorphic sarcoma in solid organ transplant recipients: a collective experience. Dermatol Surg. 2012 Feb; 38(2):230-9.
Score: 0.020
-
Ahmed S, Pfeiffer RM, Volesky-Avellaneda K, Blosser CD, Snyder JJ, Israni AK, Lynch CF, Qiao B, Rees JR, Zwald F, Yu KJ, Engels EA. Real-world evidence regarding cancer, mortality, and graft failure risk with de novo belatacept use among kidney transplant recipients in the United States. Am J Transplant. 2025 Aug; 25(8):1723-1734.
Score: 0.013
-
Blechman AB, Cabell CE, Weinberger CH, Duckworth A, Leitenberger JJ, Zwald FO, Russell MA. Aggressive Skin Cancers Occurring in Patients Treated With the Janus Kinase Inhibitor Ruxolitinib. J Drugs Dermatol. 2017 May 01; 16(5):508-511.
Score: 0.007
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|